glp-1 latest use tripled among non-diabetics, reaching $5.8B in 2022 KFF's latest Health Tracking Poll
Description
People with poorly controlled type 2 diabetes often experience fatigue due to fluctuating blood glucose levels
Contact us if youd like to request reuse of a visual asset
Additionally, the exenatide treated group exhibited lower dopamine transporter availability relative to placebo, and exploratory analyses indicated that exenatide significantly reduced both heavy drinking days and total alcohol intake among obese patients (Klausen et al., 2022)
Before first use: GLP-1 pens or vials should be kept in the refrigerator, usually between 36F-46F (2C-8C)
2E, F, H)
